ALG-097111

N/A

Report date: 2025/06/12 15:42:56
NME

Base Information

Drug NameALG-097111
Drug Alias NameALG-097111
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSARS-CoV-2-3C-like-proteinase inhibitors
TargetsSARS-CoV-2-3C-like-proteinase
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgium
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAligos Therapeutics IncCentre for Drug Design and DiscoveryRega Institute for Medical Research
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAligos Therapeutics Inc
Active IndicationsN/A
Inactive IndicationsCoronavirus Disease 2019 (COVID-19)

Other Information

ATC CodeN/A
Related LinksN/A